ArticleInternational ophthalmology2025
Classification and management of myopic traction maculopathy: a vitrectomy-based consensus from taiwanese experts.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diabetic macular atrophy, a pilot exploration of its characteristics, progression, and visual implications.Eye (London, England) · 2026Article
- Scleral imbrication combined with subretinal injection for the treatment of tractional maculopathy in pathological myopia: a case series.International journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo develop a vitrectomy-based consensus on the definition, diagnosis, and management of myopic traction maculopathy (MTM).
methodsRelevant literature was initially reviewed. Six key questions and six consensus statements were developed based on reference articles. Ten panelists then voted on the statements for consensus development.
resultsMTM was defined as maculoschisis or maculoschisis with foveal disruption, including a lamellar macular hole (LMH), full-thickness macular hole (FTMH), and macular hole with retinal detachment (MHRD). A classification combining the status of maculoschisis and the type of foveal pathology was formulated. MHRD was regarded as the end stage of the MTM. Modern optical coherence tomography images of the macula, standard color fundus photography, periodical axial length measurement, and regular visual function tests with best-corrected visual acuity and Amsler's grid were four essential tools used for the diagnosis and follow-up of MTM. FTMH and MHRD are reliable surgical indications. Surgery may be indicated for maculoschisis, with or without LMH, if visual deterioration is observed. A visual acuity of less than 20/40 was set as the relative empirical requirement for surgery. The panel reached a consensus on the use of fovea-sparing ILM peeling and the inverted ILM flap technique for MTM with various structural changes.
conclusionsThe proposed consensus on the six important aspects of the MTM may serve as a valuable reference for clinicians in relevant fields in daily practice.
Indexed as
Identifiers
40323482What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.